The FDA decision, scheduled for August 11, could mark a turning point in the treatment of PTSD. Concerns and criticisms surround the integrity of clinical trials, highlighting the lack of independent ...

Over the past few years, MDMA, also known as ecstasy or molly, has increasingly become associated with therapy and healing and could be approved next year by the U.S. Food and Drug Administration for ...

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug Administration (FDA) declined to approve a new drug application submitted ...

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock on Tuesday when an expert panel overwhelmingly voted to recommend that the Food and Drug Administration ...

This story was originally published in Group Therapy, a weekly newsletter answering questions sent by readers about what’s been weighing on their hearts and minds. Sign up here to get it in your inbox ...

We’re honored to welcome Bruce Sewick, LCPC, CADC, a nationally respected educator and clinician, for a powerful presentation on MDMA-assisted psychotherapy and its transformative potential for ...

In less than three months, the Food and Drug Administration will decide whether to approve MDMA as the first new treatment for post-traumatic stress disorder in more than two decades. It’s a landmark ...